Austasia Group (02425) Joint Venture plans to acquire 100% equity of Inner Mongolia Chifeng Boyuan Seed Cattle Breeding with 20 million yuan.
Aoyuan Group (02425) announced that on March 26, 2026, the joint venture consortium entered into an agreement with the seller, Chifeng Qiangben Agriculture and Animal Husbandry Investment (Group) Co., Ltd., whereby the joint venture consortium agreed to acquire 100% equity of Inner Mongolia Chifeng Boyuan Seed Cattle Breeding Co., Ltd. from the target company, for a total price of 20 million RMB. On March 30, 2026, the joint venture consortium had already paid the required 20 million RMB to the seller.
AUSTASIA GROUP (02425) announced that on March 26, 2026, a joint venture consortium entered into an agreement with the seller, Chifeng Qiangben Agriculture Investment (Group) Co., Ltd., to acquire 100% equity of Inner Mongolia Chifeng Boyuan Breed Cattle Breeding Co., Ltd. for a price of RMB 20 million. On March 30, 2026, the joint venture consortium has paid the required RMB 20 million to the seller.
Joint venture company A (Austasia Global (Shanghai) Livestock Co., Ltd.) and joint venture company B (Inner Mongolia Zhongao Nongtou Agricultural Co., Ltd.) formed a joint venture consortium on February 27, 2026, and submitted a bid on March 12, 2026 to acquire 100% equity of the target company, with joint venture company A acquiring 60% and joint venture company B acquiring the remaining 40%. The joint venture consortium received the winning bid notification on March 19, 2026.
Inner Mongolia Chifeng Boyuan Breed Cattle Breeding Co., Ltd. is primarily engaged in the livestock farming business in China. The acquisition of the target company is of strategic importance to the group. The Board of Directors believes that the acquisition will enable the group to ensure the continuity, quality, and safety of sourcing frozen semen in the raw milk and beef cattle business segments. In addition, with the existing genetic improvement program, the group expects to achieve synergies, improve genetic traits of the livestock, and expand the business to sell frozen semen and in vitro fertilized embryos to external customers.
Related Articles

Red Star Macalline Group Corporation (01528) released its annual performance. Shareholders' net loss amounted to 24.094 billion yuan, a year-on-year increase of 589.96%.

SAIMO (02571) released its annual performance, with its shareholders' net profit amounting to 56.265 million RMB, representing a year-on-year increase of 4.84%.

CANBRIDGE-B (01228) announced its annual performance, with a net profit of 1481.8 million yuan, turning losses into profits year-on-year.
Red Star Macalline Group Corporation (01528) released its annual performance. Shareholders' net loss amounted to 24.094 billion yuan, a year-on-year increase of 589.96%.

SAIMO (02571) released its annual performance, with its shareholders' net profit amounting to 56.265 million RMB, representing a year-on-year increase of 4.84%.

CANBRIDGE-B (01228) announced its annual performance, with a net profit of 1481.8 million yuan, turning losses into profits year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


